New Age Alpha Advisors, LLC Halozyme Therapeutics, Inc. Transaction History
New Age Alpha Advisors, LLC
- $2.27 Trillion
- Q2 2025
A detailed history of New Age Alpha Advisors, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, New Age Alpha Advisors, LLC holds 27,265 shares of HALO stock, worth $1.75 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
27,265
Previous 25,799
5.68%
Holding current value
$1.75 Million
Previous $1.65 Billion
13.84%
% of portfolio
0.06%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding HALO
# of Institutions
597Shares Held
126MCall Options Held
365KPut Options Held
317K-
Black Rock Inc. New York, NY17.6MShares$1.13 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$787 Million0.01% of portfolio
-
State Street Corp Boston, MA5.94MShares$381 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.47MShares$223 Million0.03% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.4MShares$218 Million3.92% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.95B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...